Search

everythinglearnresearchcommunity

for

Search:↓

Topical 17 alpha-propylmesterolone increases hair cell growth in androgenetic alopecia.

Bimatoprost eye drops can cause temporary eyelid changes and may help with hair growth research.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Certain drugs change freshwater snail shells to a "banana" shape.

PPCM microspheres allow controlled finasteride release over 24 hours.

Dutasteride may help reduce brain inflammation and improve cognition.

SDG helps reduce BPH effects in rats.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Dutasteride may protect brain cells in early Parkinson's, while progesterone helps neuron recovery.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Finasteride treatment can decrease certain steroids and increase others, possibly leading to depression symptoms in some cases.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

SHPro® improved urinary symptoms and erectile function in men and is safe.

Dutasteride may reduce insulin sensitivity and increase body fat.

Blocking 5α-reductase can reduce sleep deprivation-related behavioral issues in rats.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

New chemicals were made that can block an enzyme linked to hair loss, prostate growth, and acne.

Finasteride effectively treats benign prostatic hyperplasia by reducing prostate size and improving urinary symptoms.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.

Different progestins work similarly for contraception but have unique effects suited to individual needs.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

Mushroom compounds may help treat hair loss better than Finasteride.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.